Skip to main content

Table 2 Demographics, clinical syndrome and pathological subtypes assigned by 5 independent raters to FTLD-TDP cases in this study

From: Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43

Subtype Case # Age at death (y)/ Gender (M/F) Disease duration (y) Initial syndromes pTDP43 iTDP43
      Reviewer Reviewer
      1 2 3 4 5 1 2 3 4 5
A 1 76F 2 bvFTD A A A A B B A A B B
A 2 84F 8 Language FTD C A A C C A A A C A
A 3 54F 6 bvFTD A A A B A A A A A A
A 4 60M 3 Language FTD+bvFTD A A A A A A A A A A
A 5* 72M 9 bvFTD A A A A A A A A C A
A 6* 65M 2 bvFTD A C A C A A C C B A
A 7* 65F 3 bvFTD + MND B A B A A B A B B B
B 8* 55M 3 bvFTD B B B B B B B D C B
B 9 52F 1 bvFTD + MND B B B A B A B B A B
B 10 66M 2 bvFTD + MND B B B B B A B C C B
B 11 55F 2 bvFTD + MND B B B B B B B C B B
C 12 68F 1 Language FTD + MND B C C C C B C B B C
C 13 68M 12 bvFTD C C C C C C C C C C
C 14 83F 13 Language FTD C C C C C C C C C C
  1. * C9ORF72 gene mutation; bvFTD behavioral frontotemporal dementia; MND motor neuron disease.